-
A Peek Into The Market Before The Trading Starts
Tuesday, June 21, 2011 - 7:25am | 401Pre-open movers US stock futures are higher this morning, ahead of a confidence vote in the Greek parliament later in the day. Futures on the Dow Jones Industrial Average surged 46 points to 12,059.00 and futures on the S&P 500 stock index rose 5.20 points to 1,279.00. Nasdaq 100 futures gained...
-
Jefferies Reiterates Buy on Celgene Corporation
Tuesday, June 21, 2011 - 7:17am | 170Jefferies reiterates Buy on Celgene Corporation (NASDAQ: CELG). In a research report published today, Jefferies commented on the company's Revlimid product. In the report, Jefferies states, "While we agree with the Street that an increase in protocol-specified Revlimid maintenance duration in the...
-
Deutsche Bank Updates 6/21
Tuesday, June 21, 2011 - 7:03am | 455Deutsche Bank made a number of updates in a research report published today. Biogen Idec (NASDAQ: BIIB) had its rating upgraded from Hold to Buy. At the same time, Deutsche Bank raised its price target on the company's stock from $106 to $129. In the report, Deutsche Bank states, "Upgrading to...
-
Eli Lilly and Amylin Pharmaceuticals Announces BYDUREON Receives Marketing Authorization in Europe
Tuesday, June 21, 2011 - 7:00am | 106Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes, Inc. (Nasdaq: ALKS), announced today that the European Commission has granted marketing authorization to BYDUREON. BYDUREON, a glucagon-like peptide-1 receptor agonist, is the first once-...
-
Deutsche Bank Upgrades Biogen To Buy, Raises PT To $129
Tuesday, June 21, 2011 - 5:47am | 31Deutsche Bank has raised the price target on Biogen Idec (NASDAQ: BIIB) from $106 to $129 and has upgraded the company from Hold to Buy.
-
Trade Setups For 6/21
Monday, June 20, 2011 - 10:01pm | 121I've put together 4 long setups and 4 short-setups for tomorrow. It should be a wild next couple of days with Greece debt crisis coming to a head, as well as Benny-Boy holding a press-conference and releasing the FOMC statement on Wednesday. So expect anything to happen, and don't act surprised...
-
Fast Money Picks For June 21st (DE, WLT, BIIB, F)
Monday, June 20, 2011 - 6:56pm | 163On CNBC's Fast Money, Tim Seymour suggested that investors should buy Deere & Company (NYSE: DE) on Tuesday. Deere & Company (DE) gained 1.95% today, and it closed at $80.06. Guy Adami likes Walter Energy, Inc. (NYSE: WLT), and he wants to buy it tomorrow. Walter Energy, Inc. (WLT) fell 2....
-
Pluristem Therapeutics Pops on Licensing Pact
Monday, June 20, 2011 - 4:47pm | 229Pluristem Therapeutics Inc. (NASDAQ: PSTI) announced this morning that it has reached a licensing agreement with United Therapeutics (NASDAQ: UTHR) to develop and commercialize the Israel-based company's treatment for pulmonary hypertension. Under the terms of the agreement, United Therapeutics...
-
Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs
Monday, June 20, 2011 - 4:26pm | 81Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of...
-
Senesco Technologies Told by FDA It May Proceed Clinical Trials – SNS01-T IND is Open
Monday, June 20, 2011 - 4:02pm | 157Senesco Technologies (NYSE: SNT) today announced that the Company has been told by the U.S. Food and Drug Administration that all clinical hold issues have been satisfactorily addressed and the FDA has removed the clinical hold on Senesco's Investigational New Drug application. After the Company's...
-
Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock; An Additional 9M Shares
Monday, June 20, 2011 - 4:01pm | 112Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) announced today that it has commenced an underwritten public offering of an aggregate of 9,000,000 shares of its common stock. In connection with this offering, Achillion plans to grant the underwriters a 30-day option to purchase up to an additional 1...
-
Momenta Pharmaceuticals Study Showing M402 Inhibits Tumor Metastasis in Multiple Murine Oncology Models Published in PLoS One
Monday, June 20, 2011 - 3:16pm | 139Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced that results from a preclinical study of its novel oncology drug candidate, M402, were published in the on-line edition of the journal PLoS ONE. PLoS One is the online edition of the scientific journal Public Library of Science. M402...
-
Calls Purchased on GTx, Inc.
Monday, June 20, 2011 - 1:53pm | 126Shares of GTx, Inc. (NASDAQ: GTXI) are higher on the session by 10.67%, currently trading at $5.81. The stock has been moving largely higher over the past three months and is currently trading above the 200-day moving average. Options traders are buying calls on the name today. A short while ago...
-
Biotech/Pharma Stocks; Take A New Approach to Cancer
Monday, June 20, 2011 - 1:40pm | 1617Point Roberts, WA- June 17, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, reports on advances in Cancer Immunotherapy featuring Aethlon Medical (OTCBB: AEMD), Bristol-Myers Squibb Company (NYSE: BMY), Dendreon Corporation...
-
NASDAQ Stocks Hitting 52-Week Highs
Monday, June 20, 2011 - 10:07am | 156Oncothyreon Inc (NASDAQ: ONTY) shares rose 0.96% to create a new 52-week high of $8.18. ONTY shares have surged 121.92% over the past 52 weeks, while the S&P 500 index has gained 13.78% in the same period. inContact Inc (NASDAQ: SAAS) shares gained 1.64% to create a new 52-week high of $4.35....